Advertisement

 

 

Rheumatoid granulomatous disease and pachymeningitis successfully treated with rituximab.

Rheumatoid granulomatous disease and pachymeningitis successfully treated with rituximab.
Author Information (click to view)

Moeyersoons A, Verschueren P, Tousseyn T, De Langhe E,


Moeyersoons A, Verschueren P, Tousseyn T, De Langhe E, (click to view)

Moeyersoons A, Verschueren P, Tousseyn T, De Langhe E,

Advertisement

Acta clinica Belgica 2017 09 13() 1-6 doi 10.1080/17843286.2017.1375193
Abstract

Granulomatous disease and pachymeningitis rarely occur in rheumatoid arthritis patients and confer a challenging differential diagnosis. Our patient, treated with a tumor necrosis factor alpha inhibitor, presented with meningitis and diffuse granulomatous adenopathies. Opportunistic infections and malignancy were excluded after confirmation of negative broath serologic, molecular analysis, and negative cytology. Because of the time frame and the clinical presentation, this case was considered as a rare systemic manifestation of RA. He was treated with rituximab with beneficial clinical evolution. This case offers an excellent opportunity to focus on the diagnostic and therapeutic approach in pachymeningitis and granulomatous disease in rheumatoid arthritis patients.

Submit a Comment

Your email address will not be published. Required fields are marked *

9 − 6 =

[ HIDE/SHOW ]